SK281934B6 - Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia - Google Patents
Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia Download PDFInfo
- Publication number
- SK281934B6 SK281934B6 SK1614-97A SK161497A SK281934B6 SK 281934 B6 SK281934 B6 SK 281934B6 SK 161497 A SK161497 A SK 161497A SK 281934 B6 SK281934 B6 SK 281934B6
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- group
- compound
- atom
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9506564A FR2734821B1 (fr) | 1995-06-02 | 1995-06-02 | Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique |
FR9506563A FR2734820B1 (fr) | 1995-06-02 | 1995-06-02 | Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique |
PCT/FR1996/000792 WO1996038444A1 (fr) | 1995-06-02 | 1996-05-28 | Derives d'oxazolidinone, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
SK161497A3 SK161497A3 (en) | 1998-05-06 |
SK281934B6 true SK281934B6 (sk) | 2001-09-11 |
Family
ID=26232004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1614-97A SK281934B6 (sk) | 1995-06-02 | 1996-05-28 | Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia |
Country Status (27)
Country | Link |
---|---|
US (1) | US5843975A (pl) |
EP (1) | EP0835254B1 (pl) |
JP (1) | JP3856829B2 (pl) |
KR (1) | KR100457502B1 (pl) |
CN (1) | CN1075072C (pl) |
AR (1) | AR006301A1 (pl) |
AT (1) | ATE184005T1 (pl) |
AU (1) | AU699367B2 (pl) |
BR (1) | BR9608896A (pl) |
CA (1) | CA2223011C (pl) |
CO (1) | CO4700462A1 (pl) |
CZ (1) | CZ378497A3 (pl) |
DE (1) | DE69604071T2 (pl) |
DK (1) | DK0835254T3 (pl) |
ES (1) | ES2138346T3 (pl) |
GR (1) | GR3031710T3 (pl) |
HK (1) | HK1014938A1 (pl) |
HU (1) | HU224879B1 (pl) |
MX (1) | MX9709410A (pl) |
NO (1) | NO309091B1 (pl) |
NZ (1) | NZ310487A (pl) |
PL (1) | PL183919B1 (pl) |
RU (1) | RU2164226C2 (pl) |
SK (1) | SK281934B6 (pl) |
TW (1) | TW360654B (pl) |
WO (1) | WO1996038444A1 (pl) |
ZA (1) | ZA964563B (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1078632A1 (en) * | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
CA2438582C (en) * | 2001-01-31 | 2012-06-26 | Synaptic Pharmaceutical Corporation | Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
KR20040047869A (ko) * | 2001-09-26 | 2004-06-05 | 파마시아 이탈리아 에스.피.에이. | 키나제 억제제로서 활성인 아미노인다졸 유도체, 이의제조방법 및 이를 함유하는 약제학적 조성물 |
CA2637811A1 (en) * | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Benzisoxazole oxazolidinones as antibacterial agents |
US7998992B2 (en) * | 2007-03-30 | 2011-08-16 | Institute Of Medicinal Molecular Design, Inc. | Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1 |
EP2123159A1 (de) * | 2008-05-21 | 2009-11-25 | Bayer CropScience AG | (1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide |
CA2784753A1 (en) * | 2009-12-18 | 2011-06-23 | Janssen Pharmaceutica Nv | Substituted aminothiazolone indazoles as estrogen related receptor-.alpha. modulators |
AU2011218268A1 (en) * | 2010-02-17 | 2012-09-06 | Janssen Pharmaceutica Nv | Aminothiazolones as estrogen related receptor-alpha modulators |
WO2016097355A1 (en) * | 2014-12-19 | 2016-06-23 | Ge Healthcare Limited | Labelled oxazolidinone derivatives |
DE102015012050A1 (de) * | 2015-09-15 | 2017-03-16 | Merck Patent Gmbh | Verbindungen als ASIC-Inhibitoren und deren Verwendungen |
RU2637643C1 (ru) * | 2016-09-05 | 2017-12-05 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ) | Иммунодепрессант |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2653017B1 (fr) * | 1989-10-17 | 1995-05-05 | Delalande Sa | Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique. |
US5196543A (en) * | 1989-10-17 | 1993-03-23 | Delalande S.A. | 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy |
US5235063A (en) * | 1989-10-17 | 1993-08-10 | Delalande S.A. | Process of preparing by condensation certain |
US5182296A (en) * | 1989-10-26 | 1993-01-26 | Tanabe Seiyaky Co., Ltd. | Naphthyloxazolidone derivatives |
FR2671350A1 (fr) * | 1991-01-08 | 1992-07-10 | Adir | Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant. |
WO1992014418A1 (fr) * | 1991-02-20 | 1992-09-03 | Yusaku Koda | Articulateur |
-
1996
- 1996-05-28 CZ CZ973784A patent/CZ378497A3/cs unknown
- 1996-05-28 SK SK1614-97A patent/SK281934B6/sk not_active IP Right Cessation
- 1996-05-28 US US08/973,246 patent/US5843975A/en not_active Expired - Lifetime
- 1996-05-28 BR BR9608896A patent/BR9608896A/pt active IP Right Grant
- 1996-05-28 AU AU61288/96A patent/AU699367B2/en not_active Expired
- 1996-05-28 ES ES96918719T patent/ES2138346T3/es not_active Expired - Lifetime
- 1996-05-28 EP EP96918719A patent/EP0835254B1/fr not_active Expired - Lifetime
- 1996-05-28 JP JP53624596A patent/JP3856829B2/ja not_active Expired - Lifetime
- 1996-05-28 DE DE69604071T patent/DE69604071T2/de not_active Expired - Lifetime
- 1996-05-28 CA CA002223011A patent/CA2223011C/en not_active Expired - Lifetime
- 1996-05-28 RU RU98100257/04A patent/RU2164226C2/ru active
- 1996-05-28 HU HU9901349A patent/HU224879B1/hu unknown
- 1996-05-28 KR KR1019970708666A patent/KR100457502B1/ko not_active IP Right Cessation
- 1996-05-28 AT AT96918719T patent/ATE184005T1/de active
- 1996-05-28 WO PCT/FR1996/000792 patent/WO1996038444A1/fr active IP Right Grant
- 1996-05-28 NZ NZ310487A patent/NZ310487A/xx not_active IP Right Cessation
- 1996-05-28 PL PL96323673A patent/PL183919B1/pl unknown
- 1996-05-28 CN CN96195713A patent/CN1075072C/zh not_active Expired - Lifetime
- 1996-05-28 DK DK96918719T patent/DK0835254T3/da active
- 1996-05-31 CO CO96028173A patent/CO4700462A1/es unknown
- 1996-06-01 TW TW085106564A patent/TW360654B/zh not_active IP Right Cessation
- 1996-06-03 ZA ZA964563A patent/ZA964563B/xx unknown
- 1996-06-03 AR ARP960102870A patent/AR006301A1/es active IP Right Grant
-
1997
- 1997-12-01 NO NO975530A patent/NO309091B1/no not_active IP Right Cessation
- 1997-12-02 MX MX9709410A patent/MX9709410A/es unknown
-
1998
- 1998-12-30 HK HK98119245A patent/HK1014938A1/xx not_active IP Right Cessation
-
1999
- 1999-11-03 GR GR990402802T patent/GR3031710T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103429590B (zh) | 作为bace1和/或bace2抑制剂的1,4硫氮杂*/砜 | |
IL177939A (en) | Aryl piperidines or piperazines converted into pentagonal heterocyclic rings and a pharmaceutical composition containing them | |
CA2770932C (en) | Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines | |
FR2581993A1 (fr) | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique | |
FR2967674A1 (fr) | Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine | |
JPS6043064B2 (ja) | 新規イソオキサゾ−ル誘導体 | |
CA2176668C (fr) | Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant | |
EP0433149B1 (fr) | Antagonistes de la sérotonine, leur préparation et les médicaments les contenant | |
EP0350403A1 (fr) | Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant | |
JP2009256363A (ja) | 5−ht2a拮抗剤としてのオキサゾリジン類 | |
SK281934B6 (sk) | Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia | |
CA1296002C (en) | Substituted thiazoles and oxazoles, medicaments containing these compounds, and processes for their preparation | |
JP5255568B2 (ja) | 迅速に解離するドーパミン2受容体アンタゴニストとしてのピペリジニルアミノ−ピリダジンおよびそれらの使用 | |
CA1231950A (fr) | Procede d'obtention de nouveaux derives substitues du 2,5-diamino 1,4-diazole et des compositions pharmaceutiques en renfermant | |
EP0841330B1 (fr) | Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
CA3148365A1 (en) | Alpha-d-galactopyranoside derivatives | |
EP1790646A1 (fr) | Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3. | |
HU203548B (en) | Process for producing benzoxazine derivatives and pharmaceutical compositions containing them | |
JP2000219678A (ja) | ベンゼン誘導体又はピリジン誘導体 | |
FR2467205A1 (fr) | Derives d'acide benzo(ij)quinolizine carboxylique-2, utiles notamment comme medicaments antimicrobiens, procede de leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant | |
WO1997013768A1 (fr) | Composes derives d'oxazolidin-2-one, leur procede de preparation et leur application en therapeutique | |
US4985427A (en) | Triazine derivatives | |
EP1773823B1 (fr) | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique | |
FR2605008A1 (fr) | Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique | |
FR2734820A1 (fr) | Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20160528 |